← All News

ETHRA Expands GMP Manufacturing Capacity in Addis Ababa

ETHRA Pharmaceuticals expands GMP-compliant production at its 3,000m² Addis Ababa facility to increase output of tablets, capsules, liquids, and APIs for Ethiopia and export markets.

ETHRA Pharmaceuticals is strengthening Ethiopia’s pharmaceutical independence with expanded Good Manufacturing Practice (GMP) capacity at our Addis Ababa manufacturing site.

Scaling Local Production

The upgrade supports increased output of essential medicines — including antibiotics, dry powder suspensions, syrups, and active pharmaceutical ingredients (APIs) — meeting growing demand from hospitals, clinics, and distribution partners across the region.

Quality at Every Batch

Every batch is produced under strict GMP standards with full traceability from raw materials through finished dosage forms. Our quality control laboratory validates potency, purity, and stability before release.

Supporting Healthcare Access

By manufacturing locally, ETHRA reduces import dependency and helps keep critical medicines affordable and available for Ethiopian patients and regional healthcare networks.

Stay Connected with ETHRA

Partnership inquiries, product specifications, and general information — our team is ready to help.

Contact Us